Olga Shvets

Olga Shvets

Auto-generated profile, based on publicly available information

Olga Shvets

Kharkiv National Medical University, Ukraine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
ZPZ.I. Piskur
Z.I. Piskur
OKO.P. Kostyk
O.P. Kostyk
MSM.I. Sakhelashvili
M.I. Sakhelashvili
LPL.I. Pylypiv
L.I. Pylypiv
OSO.M. Shvets
O.M. Shvets
ЛПЛ.і. Пилипів
Л.і. Пилипів
Objective — to analyze the peculiarities of detection and course of various clinical forms of extrapulmo­nary tuberculosis (EPTB), the profile of drug resistance of the Mycobacterium tuberculosis (MBT) among children of different ages. Materials and methods. We retrospectively analyzed the medical data of 47 children aged 0 to 14 with local forms of EPTB, hospitalized in the pediatric department of Lviv TB hospital from 2013 to 2020. Children were divided into groups: up to 1-year-olds (19 children; group I), 2—9 year-olds (19 children; group II) and 10—14-year-olds (9 children; group III). Results and discussion. It was found that children under 1 year of age were more likely to live in rural areas than in urban areas (78.9 vs. 21.1 %; p < 0.01). Resistant forms were diagnosed among 49.0 % of children. Among children of the first year of age this number reached 73.7 %, which is probably more often than among children aged 2—9 (26.3 %; p < 0.01). The numbers of multidrug-resistant TB (MDR-TB) and the risk of MDR-TB among children under one year of age were 35.7 and 28.6 %, respectively. The most common clinical form of EPTB was TB of peripheral lymph node (PLN) regardless of age (40.4 %). Only TB of PLN and TB of meningeal and CNS were found among children under 1 year of age. Among children aged 2—9, TB of PLN and TB of bone and joints were probably more common than all other localizations. TB of bones and joints among children aged 10—14 was more common than TB of eyes and skin. The proportion of TB of meninges and CNS in group I was probably higher compared to groups II and III (p1 < 0.01; p2 < 0.05). At the same time, TB of bones and joints among children of groups II and III was diagnosed significantly more often than in group I (p1 < 0.01; p2 < 0.05).In 89.4 % of cases EPTB was combined with pulmonary TB (PTB). Among children under one year of age, miliary PTB was diagnosed probably more often than other clinical forms (p < 0.05). Bilateral lesions were probably more common among children under one year of age than in children aged 10—14 (77.8 vs. 28.6 %; p < 0.05). Unilateral lesions were more common among children aged 10—14 than in children up to one year of age (22.2 vs. 71.4 %; p < 0.05). Children under 1 year of age and 2—9-year-olds were significantly more likely to be diagnosed with EPTB when seeking medical care than during examination of contact persons (63.2 vs. 26.3 %; 68.4 vs. 31.6 %; all p < 0.05) and during the preventive examination (10.5 % and 0; all p < 0.01). Also, EPTB was found more often among children aged 10—14 (66.7 vs. 0; p < 0.01). It was found that only 36.8 % of children of group I, 42.1 % of children of group II and 33.3 % of children of group III were sent to a specialized hospital after visiting the clinic.Patients under 1 year of age and 2—9-year-olds compared with children aged 10—14 were significantly more likely to have a combination of clinical manifestations of intoxication and bronchopulmonary syndromes (47.4 and 31.6 % vs. 0; p1 < 0.05; p2 < 0.01). At the same time, intoxication syndrome was significantly more common among children aged 10—14 than among children under one year of age (88.9 vs. 26.3 %; p < 0.01). Lack of vaccination was significantly more common among children under one year of age than in the following age groups (94.7 vs. 57.9 and 44.4 %; both p < 0.05), and the proportion of ineffective vaccinations was significantly higher among children aged 10—14 than in children under 1 year of age (55.6 vs. 5.3 %; p < 0.05). Conclusions. These data indicate the need to intensify preventive TB measures among children of different ages, as well as the need for enhanced control over vaccination, regular screening, monitoring of contacts among the adult population and their controlled treatment.

1 September 2022 in Current Issues in Pharmacy and Medical Sciences
Verified
Journal Article
Open access
PDF file
ZPZoriana Ivanovna Piskur
Zoriana Ivanovna Piskur
LPLesya Pylypiv
Lesya Pylypiv
OSOlga Shvets
Olga Shvets
MSManana Sakhelashvili
Manana Sakhelashvili
OKOlga Kostyk
Olga Kostyk
OSOlga Sakhelashvili-Bil
Olga Sakhelashvili-Bil
Pediatric tuberculosis is a health problem of special significance because it is a marker for current transmission of tuberculosis in society. The research aimed at analyzing the peculiarities of detection and course of pediatric extrapulmonary tuberculosis (EPTB) taking into account the profile of drug resistance. A retrospective study of medical charts of children with EPTB (n = 47; 1st group) and pulmonary tuberculosis (PTB) (n = 49; 2nd group) aged 0-15 for 2013-2020 has been conducted. 2 subgroups with EPTB were identified separately: resistant (EPRTB) (n = 23) and sensitive (EPSTB) (n = 24). Results and discussion. The frequency of EPTB was 9.8%. Tuberculosis of peripheral LN (40.5%), CNS (27.7%), bones and joints (23.4%) was significantly more often diagnosed, than other lesions. Almost half of children with EPTB had a miliary distribution. In 44.7% of children with EPTB contact with a patient with tuberculosis was not established. EPRTB was significantly more common among children under 1 and up to 3 years of age than EPSTB. The resistance to combination of HR (73.6%) was found more often than to HRES (10.5%), HRS, H and Z (5.3% each; p<0.01). In 73.9% of children with EPRTB was detected when seeking medical care, in 13.0% the time to diagnosing lasted 6 months. Among children with EPRTB, gradual course was more frequent and in 47.8% intoxication syndrome was dominating. 78.3% of children with EPRTB were not vaccinated. Conclusion. The above indicates the need to intensify preventive measures against tuberculosis among children, especially at risk groups, make monitoring of contacts and their treatment.

29 October 2022 in Modern pediatrics. Ukraine
Verified
Journal Article
Closed access
ZPZ.I. Piskur
Z.I. Piskur
LPL.I. Pylypiv
L.I. Pylypiv
OSO.M. Shvets
O.M. Shvets
OKO.P. Kostyk
O.P. Kostyk
MSM.I. Sakhelashvili
M.I. Sakhelashvili
Pediatric tuberculosis (TB) is a serious infectious disease that affects many children worldwide and is more likely to be extrapulmonary than adult TB. The purpose - to analyze the profile of drug resistance of Mycobacterium tuberculosis and clinical features of extrapulmonary resistant (EPR) TB among children from Lviv region, Ukraine. Materials and methods. We analyzed all cases of EPR TB (n=23) and extrapulmonary sensitive (EPS) TB (n=24) among 478 medical charts of children, who were hospitalized in the Lviv Anti-TB hospital during 2013-2020. Results. It was found out that EPR TB was diagnosed significantly more often at the age of 1 year and up to 3 years old than EPS TB and significantly less often - among children aged 4-7 years. The children with EPR TB were significantly more likely to live in rural areas and they were significantly more likely to be from families with less than 2 children, compared to EPS TB. The children with EPR TB were more often diagnosed with meningeal and central nervous system (CNS) TB, less often - with TB of the bones and joints, only they had TB of the intestine, compared to EPS TB. Miliary pulmonary TB and the predominance of bilateral process were more common at EPR TB. Among children with EPR TB, rifampicin-resistant TB was significantly more common found than the risk of multidrug-resistant TB (MDR-TB) and monoresistant TB. The resistance profile of MDR-TB showed that 17.4% are resistant to the combination of HR (H-isoniazid, R-rifampicin), 8.6% - to HRES (E-ethambutol, S-streptomycin), 4.3% - to НRS. Among 43.5% of children with EPR TB the contact with a TB patient was not established. At the same time, only a third of children who had came into contact with bacterial exсretors were under dispensary observation and only about 9% received chemoprophylaxis. Conclusions. In order to prevent the development of EPR TB, it is necessary to improve TB prevention measures among the most vulnerable segments of the population. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.

29 February 2024 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
OSO.S. Shevchenko
O.S. Shevchenko
LTL.D. Todoriko
L.D. Todoriko
RSR.S. Shevchenko
R.S. Shevchenko
SMS.L. Matvyeyeva
S.L. Matvyeyeva
ЕTЕ. Tudor
Е. Tudor
ЄТЄ. Тудор
Є. Тудор
Establishing relationships between clinical and laboratory parameters, such as general patient’s state, parameters of complete blood count and blood biochemistry and markers of the course of tuberculosis in the future can be used to predict the severity of dysfunction of various organs and tissues in patients with tuberculosis and in particular in patients who receive anti-tuberculosis treatment. Objective — to investigate the relationship between biochemical markers, namely Human-beta-defensin-1, ferritin and interleukin-6, and clinical and laboratory indicators of the severity of the tuberculosis process. Materials and methods. 100 patients diagnosed with pulmonary tuberculosis were included in the study. After receiving 60 doses of anti-tuberculosis treatment, the patients were retrospectively divided into 2 groups. Group 1 (n = 77) consisted of patients in whom sputum conversion was observed after 60 doses of treatment, determined by sputum microscopy. Group 2 (n = 23) comprised patients in whom bacterial secretion was maintained after 60 doses of treatment, as detected by microscopy. In addition to the routine studies provided for the monitoring of patients with tuberculosis by the current orders of the Ministry of Health of Ukraine, the levels of Human-beta-defensin-1, ferritin and interleukin-6 (IL-6) in the fasting blood were additionally measured by ELISA at the beginning of treatment and after 60 days. Statistical data processing was carried out using the Statistica 8.0 software environment. Results. A comparison of the investigated parameters between groups at the beginning of treatment showed significantly higher values of Human-beta-defensin-1 (Group 1 — (18.97 ± 2.42) pg/ml, Group 2 — (55.02 ± ± 15.69) pg/ml), ferritin (Group 1 — (94.86 ± 6.02) ng/ml, Group 2 — (141.61 ± 24.66) ng/ml) and IL-6 (Group 1 — (80.33 ± 5.03) pg/ml, Group 2 — (110.13 ± 10.35) pg/ml) in patients with positive sputum micros­copy after 60 doses of treatment, p < 0.05. All studied markers demonstrated a reliable positive relationship with the massiveness of bacterial excretion, a conditional indicator of the severity of clinical symptoms and signs, ESR and urea level, as well as reliable negative correlations with creatinine level. In addition, patients with a lower body mass index were found to have higher levels of Human-beta-defensin-1 and ferritin. Higher levels of Human-beta-defensin-1 and ferritin are associated with lower hemoglobin levels (Human-beta-defensin-1 was also negatively correlated with erythrocyte count). An increase in the leukocytes level is accompanied by a significant increase in the level of Human-beta-defensin-1 and IL-6. Additionally, a significant negative correlation was found between the level of glucose and ferritin, as well as between the level of bilirubin and ferritin and IL-6. Conclusions. The determined significantly higher levels of Human-beta-defensin-1, ferritin and interleukin-6 in patients in whom sputum microscopy was positive after 60 doses of treatment allow considering the investigated biochemical parameters as markers of the ineffectiveness of anti-tuberculosis therapy. The identified positive relationships with the severity of clinical symptoms indicate the possibility of using the studied parameters as markers of the severity of the tuberculosis course. The possibility of using Human-beta-defensin-1 and ferritin as markers of anemia was also found. Correlations with parameters of blood biochemistry allow us to talk about increased levels of Human-beta-defensin-1, ferritin and interleukin-6 against the background of kidney damage. - Установлення зв’язків між клініко-лабораторними параметрами (загальний стан пацієнта, показники клінічного і біохімічного аналізів крові) та маркерами перебігу туберкульозу в перспективі може бути використане для прогнозування тяжкості порушення функціонування різних органів і тканин у хворих на туберкульоз, зокрема в пацієнтів, які отримують протитуберкульозне лікування.Мета роботи — дослідити зв’язки між біохімічними маркерами (β-дефензин-1, феритин, інтерлейкін-6 (ІЛ-6)) і клінічними та лабораторними показниками тяжкості туберкульозного процесу. Матеріали та методи. У дослідження було залучено 100 хворих на туберкульоз легень. Після отримання 60 доз протитуберкульозного лікування пацієнтів ретроспективно розподілили на дві групи: 77 пацієнтів, у яких зареєстрували припинення бактеріовиділення (за даними мікроскопії мокротиння), і 23 пацієнти, у яких зберігалося бактеріовиділення (за даними мікроскопії мокротиння). Крім рутинних досліджень, передбачених для моніторингу пацієнтів із туберкульозом наказами МОЗ України щодо ведення хворих на туберкульоз, вимірювали рівень β-дефензину-1, феритину та ІЛ-6 у крові натще методом імуноферментного аналізу на початку лікування та через 60 днів. Статистичну обробку даних проведено за допомогою програмного...

21 July 2021 in Inter Collegas
Verified
Journal Article
Closed access
PDF file
OSOlga Shvets
Olga Shvets
OSOlga Shevchenko
Olga Shevchenko
ZPZoriana Piskur
Zoriana Piskur
HSHanna Stepanenko
Hanna Stepanenko
OPOlha Pohorielova
Olha Pohorielova
Background. The problem of studying lipid metabolism in patients with tuberculosis is of interest to scientists around the world. The purpose of the study - to investigate lipid profile in pulmonary tuberculosis patients with concurrent insulin resistance. Materials and methods. Forty-one patients with pulmonary tuberculosis were examined. Insulin resistance index (HOMA-IR), total cholesterol level (TC), triglycerides (TG) level, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol and atherogenic index (AI) were measured. Results. Group 1 - 26 patients with tuberculosis and insulin resistance (HOMA-IR ˃ 2.7); Group 2 – 15 patients with tuberculosis without insulin resistance (HOMA-IR ˂ 2.7). Group 1 patients had severe course of TB with fever, severe fatigue and weakness, profuse sweating, weight loss, cough and shortness of breath. Median TC indices differed at significant level (p = 0.012): group 1 - 4.82 mmol/l, group 2 - 4.25 mmol/l. TG level was higher in group 1 patients - 1.32 mmol/l than in group 2 patients - 1.28 mmol/l. LDL cholesterol values were higher in group 1 patients - 3.2 mmol/l vs 2.5 mmol/l in group 2. The AI was higher in group1 (p = 0.005): 3.9 units against 2.8 units in group 2 patients. Conclusions. Insulin resistance in pulmonary tuberculosis patients was associated with severe course of the disease, severe clinical manifestations and impaired external respiration. Pro-atherogenic disorders of lipid metabolism in pulmonary tuberculosis patients with concurrent insulin resistance can be considered as the degree of endogenous intoxication.

20 September 2023 in Tuberculosis, Lung Diseases, HIV Infection
Verified
Journal Article
Open access
PDF file
OSO.S. Shevchenko
O.S. Shevchenko
LTL.D. Todoriko
L.D. Todoriko
SMS.L. Matvyeyeva
S.L. Matvyeyeva
IOI.A. Ovcharenko
I.A. Ovcharenko
OSO.M. Shvets
O.M. Shvets
OPO.O. Pohorielova
O.O. Pohorielova
Туберкульоз — поширена хвороба у багатьох країнах, тому розуміння його впливу на якість життя та функцію дихання, а також зв’язок цих показників з біохімічними маркерами перебігу й ефективності лікування туберкульозу має важливе значення для оцінки нових методів лікування та профілактики. Мета роботи — дослідити зв’язок між функцією зовнішнього дихання, рівнем β-дефензину-1, феритину, інтерлейкіну-6, якістю життя та об’ємом туберкульозного ураження легень. Матеріали та методи. У дослідження було залучено 100 пацієнтів із туберкульозом легень. Па­­цієнтів розподілили на дві групи відповідно до об’єму туберкульозного ураження: група 1 (n = 36) — ураження в межах однієї легені, група 2 (n = 64) — ураження обох легень. Обстеження пацієнтів проводили згідно зі стандартами надання медичної допомоги хворим на туберкульоз. Додатково методом імуноферментного аналізу визначали рівень феритину, інтерлейкіну (ІЛ)-6 та β-дефен­зину-1 у крові натще, проводили спірографію для визначення показників функції зовнішнього дихання, а також анкетування за опитувальником SF-36 із визначенням основних показників якості життя на початку лікування та через 60 днів. Статистичну обробку даних проводили за допомогою програмного середовища Statistica 8.0. Результати та обговорення. Порівняння спірометричних показників між групами очікувано показало статистично значущо нижчі параметри функції зовнішнього дихання у пацієнтів з двобічним туберкульозним ураженням порівняно із пацієнтами з однобічним ураженням. Зниження показників функції зовнішнього дихання супроводжувалося відповідним зниженням якості життя, більш вираженим у групі 2. Зміни відбувалися на тлі статистично значущого підвищення досліджуваних біохімічних маркерів у групі 2 порівняно з групою 1: рівень β-дефензину-1 у групі 1 становив у середньому (8,11 ± 1,78) пг/мл, у групі 2 — (30,14 ± 3,89) пг/мл (p < 0,05), феритину — відповідно (94,19 ± 1,18) і (113,45 ± 4,77) нг/мл (p < 0,05), ІЛ-6 — (81,43 ± 1,14) та (103,34 ± 3,46) пг/мл (p < 0,05). При дослідженні кореляційних зв’язків між рівнями β-дефензину-1, феритину, ІЛ-6 та показниками якості життя за опитувальником SF-36 установлено статистично значущі обернено пропорційні зв’язки між усіма показниками якості життя і рівнями β-дефензину-1 та феритину. Дослідження кореляційних зв’язків між рівнями β-дефензину-1, феритину, ІЛ-6 та показниками функції зовнішнього дихання виявило, що β-дефензин-1 має статистично значущі обернено пропорційні зв’язки як з об’ємними, так і зі швидкісними показниками (– 0,24… – 0,32), ІЛ-6 — лише із форсованою життєвою ємністю легень (rs = – 0,42) та об’ємом форсованого видиху за першу секунду (rs = – 0,41), але ці кореляційні зв’язки є сильнішими порівняно з β-дефензином-1. Висновки. Збільшення об’єму туберкульозного ураження легень призводить до виразнішого порушення функції зовнішнього дихання і, як наслідок, — до зниження якості життя пацієнтів. Ці зміни супроводжуються підвищенням рівня β-дефензину-1, феритину та ІЛ-6, тому зазначені біомаркери є перспективними предикторами погіршення функції зовнішнього дихання та якості життя. Сильніші кореляції з показниками якості життя продемонстрували β-дефензин-1 та феритин. Досліджувані маркери мають обернено пропорційні зв’язки із показниками як рестриктивних, так і обструктивних...